Jessica Potts j.e.potts@keele.ac.uk
Percutaneous Coronary Intervention in Cancer Patients: A Report of the Prevalence and Outcomes in the United States
Potts, JE; Lopez Mattei, JC; Martinez, SC; Fischman, DL; Mamas, M; Iliescu, CA; Holmvang, L; Kwok, CS; Ludman, P; De Belder, MA; Rashid, M
Authors
JC Lopez Mattei
SC Martinez
DL Fischman
Mamas Mamas m.mamas@keele.ac.uk
CA Iliescu
L Holmvang
CS Kwok
P Ludman
MA De Belder
Muhammad Rashid m.rashid@keele.ac.uk
Abstract
This study aims to examine the temporal trends and outcomes in patients who undergo percutaneous coronary intervention (PCI) with a previous or current diagnosis of cancer, according to cancer type and the presence of metastases.
Methods and results
Individuals undergoing PCI between 2004 and 2014 in the Nationwide Inpatient Sample were included in the study. Multivariable analyses were used to determine the association between cancer diagnosis and in-hospital mortality and complications. 6 571 034 PCI procedures were included and current and previous cancer rates were 1.8% and 5.8%, respectively. Both rates increased over time and the four most common cancers were prostate, breast, colon, and lung cancer. Patients with a current lung cancer had greater in-hospital mortality (odds ratio (OR) 2.81, 95% confidence interval (95% CI) 2.37–3.34) and any in-hospital complication (OR 1.21, 95% CI 1.10–1.36), while current colon cancer was associated with any complication (OR 2.17, 95% CI 1.90–2.48) and bleeding (OR 3.65, 95% CI 3.07–4.35) but not mortality (OR 1.39, 95% CI 0.99–1.95). A current diagnosis of breast was not significantly associated with either in-hospital mortality or any of the complications studied and prostate cancer was only associated with increased risk of bleeding (OR 1.41, 95% CI 1.20–1.65). A historical diagnosis of lung cancer was independently associated with an increased OR of in-hospital mortality (OR 1.65, 95% CI 1.32–2.05).
Conclusions
Cancer among patients receiving PCI is common and the prognostic impact of cancer is specific both for the type of cancer, presence of metastases and whether the diagnosis is historical or current. Treatment of patients with a cancer diagnosis should be individualized and involve a close collaboration between cardiologists and oncologists.
Acceptance Date | Oct 25, 2018 |
---|---|
Publication Date | Jun 7, 2019 |
Publicly Available Date | Mar 28, 2024 |
Journal | European Heart Journal |
Print ISSN | 0195-668X |
Publisher | Oxford University Press |
Pages | 1790-+ |
DOI | https://doi.org/10.1093/eurheartj/ehy769 |
Keywords | PCI, cancer, complications, mortality |
Publisher URL | https://doi.org/10.1093/eurheartj/ehy769 |
Files
Manuscript resubmission october2018 OA.docx
(174 Kb)
Document
Publisher Licence URL
https://creativecommons.org/licenses/by-nc/4.0/
You might also like
Hypertensive disorders of pregnancy and impact on in-hospital cardio-obstetric outcomes
(2020)
Presentation / Conference
In-hospital Upper Gastrointestinal Bleeding Following Percutaneous Coronary Intervention
(2020)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search